Patents by Inventor Christopher C. Adam

Christopher C. Adam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7249043
    Abstract: A method of providing a limited resource to a plurality of users that aggregates the plurality of users into a purchasing block, arranges for the availability of the resource and regulates the use of the resource by each of the users based on each of the user's need for the resource so that a particular user having a greater need for the resource receives a greater provision of the resource while controlling usage of the resource to maintain aggregated usage below a predetermined level. The method is implemented through the use of an aggregation controller and a plurality of consumer resource controllers located at consumers' facilities. Communication between the aggregation controller and the consumer resource controllers is achieved through the use of a communication network, such as the Internet.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: July 24, 2007
    Assignee: E.P.M., Inc.
    Inventors: Benjamin H. Trout, II, James O. Johnson, Christopher C. Adam
  • Patent number: 7122316
    Abstract: The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: October 17, 2006
    Assignee: Gen-Probe Incorporated
    Inventors: Christopher C. Adams, Steven T. Brentano, Gary P. Schroth
  • Publication number: 20040214183
    Abstract: The present disclosure provides methods for profiling, in a global manner, the activity of gene regulatory elements in cells, preferably eukaryotic and prokaryotic cells. The methods include use of Fluorescence Polarization and other homogeneous assays, regulatory element activity profiling (REAP), and electrophoretic mobility shift assays. Cells may be in any state of metabolism, whether resting, growing, normal, mutant, diseased or differentiating.
    Type: Application
    Filed: March 15, 2004
    Publication date: October 28, 2004
    Inventors: Mary E. Warren Harper, Christopher C. Adams, Paul Labbart, Marc Ballivet
  • Publication number: 20030157547
    Abstract: The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.
    Type: Application
    Filed: February 27, 2003
    Publication date: August 21, 2003
    Inventors: Christopher C. Adams, Steven T. Brentano, Gary P. Schroth
  • Patent number: 6602668
    Abstract: The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: August 5, 2003
    Assignee: Gen-Probe Incorporated
    Inventors: Christopher C. Adams, Steven T. Brentano, Gary P. Schroth
  • Publication number: 20020038016
    Abstract: The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.
    Type: Application
    Filed: May 29, 2001
    Publication date: March 28, 2002
    Inventors: Christopher C. Adams, Steven T. Brentano, Gary P. Schroth
  • Patent number: 6297365
    Abstract: The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: October 2, 2001
    Assignee: Gen-Probe Incorporated
    Inventors: Christopher C. Adams, Steven T. Brentano, Gary P. Schroth